These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31097354)

  • 21. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Nakayama M; Sakai E; Echizen K; Yamada Y; Oshima H; Han TS; Ohki R; Fujii S; Ochiai A; Robine S; Voon DC; Tanaka T; Taketo MM; Oshima M
    Oncogene; 2017 Oct; 36(42):5885-5896. PubMed ID: 28628120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HSP27 expression in primary colorectal cancers is dependent on mutation of KRAS and PI3K/AKT activation status and is independent of TP53.
    Ghosh A; Lai C; McDonald S; Suraweera N; Sengupta N; Propper D; Dorudi S; Silver A
    Exp Mol Pathol; 2013 Feb; 94(1):103-8. PubMed ID: 22982087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer.
    Zhang Z; Wang M; Zhou L; Feng X; Cheng J; Yu Y; Gong Y; Zhu Y; Li C; Tian L; Huang Q
    J Exp Clin Cancer Res; 2015 May; 34(1):51. PubMed ID: 25986235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
    PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
    Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
    Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations Between Loss of ARID1A Expression and Clinicopathologic and Genetic Variables in T1 Early Colorectal Cancer.
    Kishida Y; Oishi T; Sugino T; Shiomi A; Urakami K; Kusuhara M; Yamaguchi K; Kitagawa Y; Ono H
    Am J Clin Pathol; 2019 Sep; 152(4):463-470. PubMed ID: 31263894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The relationship between p53 protein and c-erb B-2 expression and apoptosis in colorectal cancer].
    He Q; Ohaki Y; Tanaka N; Asano G
    Nihon Ika Daigaku Zasshi; 1999 Jun; 66(3):181-7. PubMed ID: 10401235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
    Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
    Int J Cancer; 2010 Jun; 126(11):2563-74. PubMed ID: 19856315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.
    Tan J; Wang HL; Yang J; Liu QQ; Li CM; Wang YQ; Fu LN; Gao QY; Chen YX; Fang JY
    Theranostics; 2020; 10(13):5763-5777. PubMed ID: 32483417
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between autophagy and KRAS mutation with clinicopathological variables in colorectal cancer patients.
    Awi NJ; Yap HY; Armon S; Low JSH; Peh KB; Peh SC; Lee CS; Teow SY
    Malays J Pathol; 2021 Aug; 43(2):269-279. PubMed ID: 34448791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.
    Zhou S; Lu J; Li Y; Chen C; Cai Y; Tan G; Peng Z; Zhang Z; Dong Z; Kang T; Tang F
    J Exp Clin Cancer Res; 2018 Nov; 37(1):284. PubMed ID: 30477538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival.
    Noble P; Vyas M; Al-Attar A; Durrant S; Scholefield J; Durrant L
    Br J Cancer; 2013 May; 108(10):2097-105. PubMed ID: 23591201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression.
    Zhao J; Ni H; Ma Y; Dong L; Dai J; Zhao F; Yan X; Lu B; Xu H; Guo Y
    Hum Pathol; 2007 Feb; 38(2):293-8. PubMed ID: 17097132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
    Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Sulik M; Kmiec Z
    Oncol Rep; 2017 Jul; 38(1):201-210. PubMed ID: 28586030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
    Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
    Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma.
    Xie D; Sham JS; Zeng WF; Lin HL; Bi J; Che LH; Hu L; Zeng YX; Guan XY
    Hum Pathol; 2005 Jul; 36(7):777-83. PubMed ID: 16084947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AKT2 suppresses pro-survival autophagy triggered by DNA double-strand breaks in colorectal cancer cells.
    Seiwert N; Neitzel C; Stroh S; Frisan T; Audebert M; Toulany M; Kaina B; Fahrer J
    Cell Death Dis; 2017 Aug; 8(8):e3019. PubMed ID: 28837154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.